Abstract
We review new data on the epidemiology of chronic prostatitis. These population-based studies used reasonable case-definitions to survey various populations from North America, Europe and Asia. Overall, 2–10% of adult men suffer from symptoms compatible with chronic prostatitis at any time and approximately 15% of men suffer from symptoms of prostatitis at some point in their lives. Other epidemiologic data suggest that chronic prostatitis may be associated with an increased risk for development of benign prostatic hyperplasia and prostate cancer. These data suggest that chronic prostatitis is an important international health care problem that merits increased priority from clinicians and researchers.
Similar content being viewed by others
References
Cheah PY, Liong HL, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN (2003) Chronic prostatitis: symptom survey with follow-up clinical evaluation. Urology 61:60–64
Cheah PY, Liong HL, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN (2003) Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo-controlled trial. J Urol 169:592-96
Collins MM, Stafford RS, O'Leary MP, Barry MJ (1998) How common is prostatitis? A national survey of physician visits. J Urol 159:1224–1228
Collins MM, Meigs JB, Barry MJ, Walker Corkery E, Giovannucci E, Kawachi I (2002) Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 167:1363–1366
Dennis LK, Lynch CF, Torner JC (2002) Epidemiologic association between prostatitis and prostate cancer. Urology 60:78–83
Giovannucci E (2001) Medical history and etiology of prostate cancer. Epidemiol Rev 23:159–162
Isaacs JT, Coffey DS (1989) Etiology and disease process of benign prostatic hyperplasia. Prostate (Suppl 2):33–50
Kunishima Y, Takeyama K, Shimizu T et al. (2002) Prevalence of prostatitis-like symptoms in men determined by the NIH Chronic Prostatitis Symptom Index. A population-based study in a town in Hokkaido, Japan. J Urol (Supplement) (Abstract) 165
Kunishima Y, Matsukawa M, Takahashi S et al. (2002) National Institutes of Health Chronic Prostatitis Symptom Index for Japanese men. Urology 60:74–77
Mehik A, Hellstrom P, Lukkarinen O, Sarpola A, Jarvelin M (2000) Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. BJU Int 86:443–448
Moon TD, Hagen L, Heisey DM (1997) Urinary symptomatology in younger men. Urology 50:700–703
Nickel JC, Downey J, Hunter D, Clark J (2001) Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol 165:842–845
Roberts RO, Lieber MM, Rhodes T, Girman CJ, Bostwick DG, Jacobsen SJ (1998) Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology 51:578–584
Roberts RO, Jacobson DJ, Girman CJ, Rhodes T, Lieber MM, Jacobsen SJ (2002) Prevalence of prostatitis-like symptoms in a community based cohort of older men. J Urol 168:2467–2471
Stamey T (1980) Urinary infections in males. Pathogenesis and treatment of urinary tract infections. Williams and Wilkins, Baltimore, pp 342–429
Tan JK, Png DJ, Liew LC, Li MK, Wong ML (2002) Prevalence of prostatitis-like symptoms in Singapore: a population-based study. Singapore Med J 43:189–193
Zhu K, McKnight B, Stergachis A, Daling JR, Levine RS (1999) Comparison of self-report data and medical records data: results from a case-control study on prostate cancer. Int J Epidemiol 28:409–17
Acknowledgement
Partially supported by grant no. RO1 DK38955 from the National Institutes of Health, Bethesda, MD, USA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krieger, J.N., Riley, D.E., Cheah, P.Y. et al. Epidemiology of prostatitis: new evidence for a world-wide problem. World J Urol 21, 70–74 (2003). https://doi.org/10.1007/s00345-003-0329-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-003-0329-0